HCA Healthcare, Inc. (NYSE:HCA) Shares Sold by Hennion & Walsh Asset Management Inc.

Hennion & Walsh Asset Management Inc. lowered its position in HCA Healthcare, Inc. (NYSE:HCA) by 38.7% in the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 2,975 shares of the company’s stock after selling 1,882 shares during the period. Hennion & Walsh Asset Management Inc.’s holdings in HCA Healthcare were worth $1,209,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Capital World Investors lifted its holdings in HCA Healthcare by 57.5% during the first quarter. Capital World Investors now owns 2,792,377 shares of the company’s stock valued at $931,342,000 after purchasing an additional 1,019,750 shares in the last quarter. Lee Danner & Bass Inc. acquired a new stake in HCA Healthcare in the 2nd quarter worth about $131,527,000. Darsana Capital Partners LP raised its holdings in shares of HCA Healthcare by 53.3% during the second quarter. Darsana Capital Partners LP now owns 1,150,000 shares of the company’s stock valued at $369,472,000 after acquiring an additional 400,000 shares during the last quarter. Swedbank AB purchased a new stake in shares of HCA Healthcare during the first quarter worth approximately $95,882,000. Finally, TD Asset Management Inc boosted its stake in HCA Healthcare by 30.4% during the 1st quarter. TD Asset Management Inc now owns 721,318 shares of the company’s stock worth $240,581,000 after purchasing an additional 168,093 shares during the last quarter. Hedge funds and other institutional investors own 62.73% of the company’s stock.

HCA Healthcare Price Performance

Shares of NYSE HCA opened at $363.55 on Friday. The stock’s 50-day moving average is $395.06 and its two-hundred day moving average is $352.71. The company has a debt-to-equity ratio of 27.11, a current ratio of 1.06 and a quick ratio of 0.94. HCA Healthcare, Inc. has a 1-year low of $220.55 and a 1-year high of $417.14. The company has a market cap of $93.82 billion, a price-to-earnings ratio of 17.07, a price-to-earnings-growth ratio of 1.52 and a beta of 1.67.

HCA Healthcare Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Friday, December 13th will be given a dividend of $0.66 per share. The ex-dividend date is Friday, December 13th. This represents a $2.64 annualized dividend and a dividend yield of 0.73%. HCA Healthcare’s dividend payout ratio (DPR) is currently 12.39%.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on HCA. Wells Fargo & Company boosted their price target on shares of HCA Healthcare from $365.00 to $395.00 and gave the stock an “equal weight” rating in a research report on Tuesday, October 22nd. Oppenheimer lifted their price objective on HCA Healthcare from $345.00 to $390.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 24th. Morgan Stanley assumed coverage on HCA Healthcare in a research note on Tuesday, September 3rd. They issued an “equal weight” rating and a $427.00 target price for the company. KeyCorp began coverage on shares of HCA Healthcare in a research report on Friday, October 11th. They set an “overweight” rating and a $475.00 price objective for the company. Finally, Cantor Fitzgerald reissued an “overweight” rating and issued a $392.00 price target on shares of HCA Healthcare in a research note on Tuesday, October 1st. Five investment analysts have rated the stock with a hold rating, twelve have issued a buy rating and four have assigned a strong buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $377.17.

Insider Activity

In other HCA Healthcare news, SVP Kathleen M. Whalen sold 2,987 shares of the stock in a transaction that occurred on Wednesday, July 31st. The shares were sold at an average price of $363.51, for a total value of $1,085,804.37. Following the transaction, the senior vice president now directly owns 9,454 shares in the company, valued at $3,436,623.54. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. In other news, EVP Michael S. Cuffe sold 8,358 shares of HCA Healthcare stock in a transaction on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total value of $3,221,340.36. Following the transaction, the executive vice president now directly owns 29,678 shares of the company’s stock, valued at $11,438,494.76. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, SVP Kathleen M. Whalen sold 2,987 shares of HCA Healthcare stock in a transaction on Wednesday, July 31st. The shares were sold at an average price of $363.51, for a total transaction of $1,085,804.37. Following the completion of the transaction, the senior vice president now owns 9,454 shares in the company, valued at approximately $3,436,623.54. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 15,345 shares of company stock worth $5,747,945. 1.60% of the stock is currently owned by insiders.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.